Oral health-related quality of life is more strongly correlated with mental health than with oral health in relapsing-remitting multiple sclerosis.


Journal

Journal of oral rehabilitation
ISSN: 1365-2842
Titre abrégé: J Oral Rehabil
Pays: England
ID NLM: 0433604

Informations de publication

Date de publication:
Jan 2023
Historique:
revised: 25 08 2022
received: 30 05 2022
accepted: 17 10 2022
pubmed: 28 10 2022
medline: 20 12 2022
entrez: 27 10 2022
Statut: ppublish

Résumé

Multiple sclerosis (MS) is a leading cause of neurological disability in young and middle-aged populations, associated with substantial burden of illness. Because a growing literature now shows that this burden extends to poorer oral health, oral health-related quality of life (OHRQoL) may be reduced as well. To test whether people with relapsing-remitting MS (RRMS) have poorer OHRQoL than demographically matched controls, and to establish which variables are associated with worse OHRQoL. In total, 64 people with RRMS and 69 demographically matched controls participated. Both groups completed the Oral Health Impact Profile (OHIP-14), a validated measure of OHRQoL, as well as an objective oral health examination performed by a qualified dentist, a measure of dental-related functionality and a measure of mental health. OHRQoL was significantly poorer in the RRMS relative to the control group. However, although poorer OHRQoL in the RRMS group was moderately associated with objectively assessed oral health (r = .30), it was more strongly associated with mental health (r = .61). For the control group, the reverse pattern of association was evident, with OHRQoL more strongly associated with oral health (r = .48) relative to mental health (r = .20). People with RRMS report poorer OHRQoL than demographically matched controls, but these appraisals are more strongly linked to mental health than to objective oral health indicators.

Sections du résumé

BACKGROUND BACKGROUND
Multiple sclerosis (MS) is a leading cause of neurological disability in young and middle-aged populations, associated with substantial burden of illness. Because a growing literature now shows that this burden extends to poorer oral health, oral health-related quality of life (OHRQoL) may be reduced as well.
OBJECTIVES OBJECTIVE
To test whether people with relapsing-remitting MS (RRMS) have poorer OHRQoL than demographically matched controls, and to establish which variables are associated with worse OHRQoL.
MATERIALS AND METHODS METHODS
In total, 64 people with RRMS and 69 demographically matched controls participated. Both groups completed the Oral Health Impact Profile (OHIP-14), a validated measure of OHRQoL, as well as an objective oral health examination performed by a qualified dentist, a measure of dental-related functionality and a measure of mental health.
RESULTS RESULTS
OHRQoL was significantly poorer in the RRMS relative to the control group. However, although poorer OHRQoL in the RRMS group was moderately associated with objectively assessed oral health (r = .30), it was more strongly associated with mental health (r = .61). For the control group, the reverse pattern of association was evident, with OHRQoL more strongly associated with oral health (r = .48) relative to mental health (r = .20).
CONCLUSION CONCLUSIONS
People with RRMS report poorer OHRQoL than demographically matched controls, but these appraisals are more strongly linked to mental health than to objective oral health indicators.

Identifiants

pubmed: 36301199
doi: 10.1111/joor.13387
pmc: PMC10100121
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

62-68

Subventions

Organisme : Australian Research Council
Organisme : Metro South Health Research Support Scheme.

Informations de copyright

© 2022 The Authors. Journal of Oral Rehabilitation published by John Wiley & Sons Ltd.

Références

Int J Environ Res Public Health. 2020 Jun 04;17(11):
pubmed: 32512730
J Neurol Neurosurg Psychiatry. 2017 Aug;88(8):697-708
pubmed: 28285265
Mult Scler Relat Disord. 2022 Feb;58:103393
pubmed: 35216774
J Oral Rehabil. 2023 Jan;50(1):62-68
pubmed: 36301199
Sci Rep. 2018 Jun 11;8(1):8871
pubmed: 29891862
J Am Geriatr Soc. 2017 Mar;65(3):580-585
pubmed: 28152161
J Alzheimers Dis. 2018;63(3):1015-1024
pubmed: 29710711
Neurology. 2021 Nov 9;97(19):e1886-e1897
pubmed: 34649879
Front Neurol. 2019 Mar 20;10:261
pubmed: 30949122
Mult Scler. 2019 Oct;25(11):1543-1546
pubmed: 29775164
Neurol Sci. 2021 Mar;42(3):835-845
pubmed: 33411192
Aust Dent J. 2017 Sep;62(3):331-336
pubmed: 28276076
Am J Public Health. 2012 Mar;102(3):411-8
pubmed: 22390504
Gen Hosp Psychiatry. 2021 Nov-Dec;73:16-23
pubmed: 34508992
Neuropsychology. 2022 Feb;36(2):140-149
pubmed: 34968126
Spec Care Dentist. 2020 Jan;40(1):71-78
pubmed: 31858622
Community Dent Oral Epidemiol. 2020 Apr;48(2):89-100
pubmed: 31815299
J Periodontol. 1967 Nov-Dec;38(6):Suppl:602-10
pubmed: 5237683
Lancet Neurol. 2018 Feb;17(2):162-173
pubmed: 29275977
J Psychosom Res. 2002 Feb;52(2):69-77
pubmed: 11832252
Neurology. 1983 Nov;33(11):1444-52
pubmed: 6685237
Community Dent Oral Epidemiol. 1997 Aug;25(4):284-90
pubmed: 9332805
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
Qual Life Res. 2022 Feb;31(2):497-506
pubmed: 34228241
Clin Oral Investig. 2022 Mar;26(3):2899-2907
pubmed: 34773142

Auteurs

Matthew R Nangle (MR)

School of Dentistry, The University of Queensland, Brisbane, Queensland, Australia.

Nithin Manchery (N)

School of Dentistry, The University of Queensland, Brisbane, Queensland, Australia.

Andrew Swayne (A)

Department of Neurology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
Mater Centre for Neuroscience, Mater Hospital, Brisbane, Queensland, Australia.

Helen Boocock (H)

Surgical, Treatment and Rehabilitation Service (STARS), Metro North Hospital and Health Service, Queensland Health, Brisbane, Australia.

Stefan Blum (S)

Department of Neurology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
Mater Centre for Neuroscience, Mater Hospital, Brisbane, Queensland, Australia.

Julie D Henry (JD)

School of Psychology, The University of Queensland, Brisbane, Queensland, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH